Bender Robert & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,343
Closed -$661K 67
2024
Q2
$661K Buy
+5,343
New +$688K 0.15% 30

Other funds holding MRK

Bender Robert & Associates's MRK Position: Q1 2026 in Review

Bender Robert & Associates reduced its Merck (MRK) stake by 8.1% in Q1 2026, selling an estimated $41.6K and leaving 4,077 shares worth $490K. The position accounts for 0.12% of the portfolio, ranked #33.

Bender Robert & Associates first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $953K in Q4 2022. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Bender Robert & Associates held 4,077 shares of Merck worth $490K as of Q1 2026.
  • Bender Robert & Associates sold 360 Merck shares in Q1 2026, an estimated $41.6K.
  • Merck made up 0.12% of Bender Robert & Associates's portfolio in Q1 2026, its #33 holding.
  • Bender Robert & Associates first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
  • Bender Robert & Associates's Merck position peaked at $953K in Q4 2022.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bender Robert & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.